Department of Health and Social Care
£10 million to develop vaccines against global infectious diseases
The UK-aid funding for the Coalition for Epidemic Preparedness Innovations will help develop vaccines against infectious diseases like Ebola.
The UK government will give £10 million of funding to the Coalition for Epidemic Preparedness Innovations (CEPI) to help develop vaccines against emerging infectious diseases.
The £10 million is UK-aid funding that prioritises helping low- and middle-income countries.
CEPI is a global coalition that was formed in response to the Ebola epidemic in West Africa. The epidemic killed more than 11,000 people.
The importance of CEPI’s work is highlighted by outbreaks of emerging infectious diseases seen across the world in the past year, including the ongoing outbreak of Ebola in the Democratic Republic of Congo and outbreaks of Lassa fever in Nigeria and Nipah in India.
Since its launch in 2017, CEPI has received more than $740 million of funding from governments and charitable organisations around the world.
The £10 million funding is in addition to the UK’s investment of £120 million for the UK Vaccine Network (UKVN). The UKVN helps to develop vaccines and vaccine technology for epidemic diseases.
The UKVN funds 78 research projects that are developing vaccines against diseases that can cause epidemics. The UKVN is prioritising vaccine development for 12 pathogens, 5 of which are also prioritised by CEPI.
The 2 initiatives working together is further shown by the development of a promising new vaccine platform by Imperial College with UKVN support. The platform recently received further funding from CEPI to progress towards clinical use.
This funding from the UK government comes as CEPI celebrates its second anniversary at the World Economic Forum in Davos.
Secretary of State for Health and Social Care Matt Hancock yesterday said:
Diseases like Ebola and Lassa fever tear communities and families apart, causing untold amounts of harm and suffering. As a global community, we must keep trying to find new ways to beat diseases like this and making them a thing of the past.
We have a proud history of being at the forefront of tackling diseases around the world, such as the Ebola outbreak in 2014, and will continue to do so by backing this vital work with CEPI to help protect people everywhere.
Latest News from
Department of Health and Social Care
Paramedic students will get £5,000 support payment each year20/01/2020 14:38:00
Students studying to become paramedics, radiographers and physiotherapists will be among those receiving the new financial support from September.
A skills and knowledge framework for Health Impact Assessment20/01/2020 10:37:00
How the Wales Health Impact Assessment Support Unit used the Public Health Skills and Knowledge Framework to review their training strategy and shape practice.
HIV in the UK: towards zero HIV transmissions by 203017/01/2020 10:10:10
A new report by Public Health England shows that HIV transmission in the UK has continued to fall.
UK Government tackles heart disease with new partnership15/01/2020 13:10:00
The UK Government has announced its intent to pursue an innovative new collaboration to tackle heart disease with pharmaceutical company Novartis.
NHS funding bill enters Parliament15/01/2020 12:10:00
The NHS Long Term Plan Funding Bill will enshrine in law an extra £33.9 billion a year by 2024 for the NHS.
New heart disease drug to be made available for NHS patients14/01/2020 14:15:00
The government is collaborating with pharmaceutical company Novartis to launch a clinical trial for new cholesterol treatment.
Patients get same-day appointments with local pharmacists13/01/2020 15:10:00
People with minor illnesses or who need medicine urgently have been referred to local pharmacies, relieving pressure on doctors.
Wuhan novel coronavirus and avian flu: advice for travel to China13/01/2020 10:10:10
PHE is aware of a reported outbreak of a novel coronavirus in Wuhan City, China, and has offered advice to travellers to the area regarding this as well as the ongoing avian flu risk.